# FDA recall D-0140-2020

> **Macleods Pharma Usa Inc** · Class II · drug recall initiated 2019-09-23.

## Product

Pioglitazone Hydrochloride Tablets USP 15 mg, 30 count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India  NDC 33342-054-07

## Reason for recall

Superpotent

## Distribution

Product was shipped to 8 distributors who may have further distributed the product.

## Key facts

- **Recall number:** D-0140-2020
- **Recalling firm:** Macleods Pharma Usa Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-09-23
- **Report date:** 2019-10-23
- **Termination date:** 2021-02-23

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Plainsboro, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0140-2020

## Citation

> AI Analytics. FDA recall D-0140-2020. Retrieved 2026-05-29 from https://api.ai-analytics.org/recall/D-0140-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*